Neurotransmitter Agents
Showing 1 - 25 of 5,623
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022
Pain, Postoperative, Pain, Acute, Pain, Chronic Trial in Athens (lidocaine-magnesium infusion, lidocaine-ketamine infusion,
Recruiting
- Pain, Postoperative
- +10 more
- lidocaine-magnesium infusion
- +2 more
-
Athens, GreeceAretaieion University Hospital
Oct 25, 2022
Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)
Recruiting
- Prader-Willi Syndrome
- +20 more
- Guanfacine Extended Release
- Placebo
-
Brooklyn, New YorkMaimonides Medical Center
Dec 20, 2022
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156
Recruiting
- Schizophrenia
- +11 more
- LY03010 156 mg treatment group, deltoid
- +3 more
-
Little Rock, Arkansas
- +8 more
Apr 11, 2022
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)
Active, not recruiting
- Schizophrenia
- +11 more
- LY03010; paliperidone palmitate
- INVEGA SUSTENNA
-
Garden Grove, California
- +8 more
Nov 19, 2021
Depression, Unipolar Trial (Intravenous Ketamine)
Not yet recruiting
- Depression, Unipolar
- Intravenous Ketamine
- (no location specified)
Aug 6, 2023
Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurotransmitters evaluation by MRS
-
Kfar Saba, Israel
- +1 more
Jul 14, 2022
Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)
Not yet recruiting
- Basic Science
- Lysergic Acid Diethylamide Tartrate
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Jul 11, 2023
Peripheral Nerve Block, Anxiety, Preoperative Anxiety Trial in Philadelphia (Music, Midazolam)
Recruiting
- Peripheral Nerve Block
- +2 more
- Music
- Midazolam
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 3, 2022
Glabellar Frown Lines (GL), Lateral Canthal Lines (LCL) Trial in Canada, United States (botulinum toxin neuromodulator, Placebo)
Completed
- Glabellar Frown Lines (GL)
- Lateral Canthal Lines (LCL)
- botulinum toxin neuromodulator
- Placebo
-
Encino, California
- +11 more
Aug 24, 2022
Low Intensity Focussed Ultrasound Trial in Toronto (Carbamazepine, Lorazepam, Dextromethorphan)
Recruiting
- Low Intensity Focussed Ultrasound
- Carbamazepine
- +4 more
-
Toronto, Ontario, CanadaToronto Western Hospital
May 18, 2022
Social Anxiety Disorder Trial in Portland (MDMA, Psychotherapy)
Enrolling by invitation
- Social Anxiety Disorder
- MDMA
- Psychotherapy
-
Portland, OregonPortland Psychotherapy Clinic, Research, & Training Center
Jan 20, 2023
Post-Traumatic Stress Disorders, MDD Trial in Minneapolis (Ketamine, Normal Saline)
Recruiting
- Post-Traumatic Stress Disorders
- Major Depressive Disorder
- Ketamine
- Normal Saline
-
Minneapolis, MinnesotaMinneapolis Veterans Affairs Health Care System
Jan 13, 2022
Neurotoxicity of Anesthesia in Middle Aged Patients
Active, not recruiting
- Anesthesia; Adverse Effect
- Anesthesia Agent
-
Tanta, EgyptTanta University, Faculty of Medicine
Mar 14, 2022
Methamphetamine Use Disorder Trial in Lexington (Methamphetamine, Methylphenidate, Placebo oral capsule)
Completed
- Methamphetamine Use Disorder
- Methamphetamine
- +3 more
-
Lexington, Kentucky
- +1 more
Jan 14, 2022
Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in New York (Beta blocker)
Recruiting
- Heart Failure
- +4 more
- Beta blocker
-
New York, New YorkWeill Cornell Medicine
Jan 31, 2023
Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%
Recruiting
- Glaucoma
- OHT - Ocular Hypertension
- Timolol 0.5% ophthalmic solution
- Latanoprost 0.005% Ophthalmic Solution
-
Rochester, Minnesota
- +2 more
Jul 15, 2022
Functional Gastrointestinal Disorders, Dyspepsia, Psychosomatic Disorder Trial in Shanghai (Zhizhu Kuanzhong capsules (ZZKZ),
Recruiting
- Functional Gastrointestinal Disorders
- +2 more
- Zhizhu Kuanzhong capsules (ZZKZ)
- Doxepin Hydrochloride (Doxepin)
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 8, 2022
Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)
Recruiting
- Postmenopausal Symptoms
- +2 more
- Cholinergic antagonist
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
PTSD, Alcohol Use Disorder Trial in Baltimore (Pregabalin plus BBCET, Placebo plus BBCET)
Active, not recruiting
- PTSD
- Alcohol Use Disorder
- Pregabalin plus BBCET
- Placebo plus BBCET
-
Baltimore, MarylandUniversity of Maryland School of Medicine
Mar 25, 2022
Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)
Completed
- Retinitis Pigmentosa
- Wharton's jelly derived mesenchymal stemcells
- Magnovision
-
Ankara, Gölbaşı, Turkey
- +2 more
Mar 23, 2023
Neurogenic Dysfunction of the Urinary Bladder, Multiple Sclerosis, Sacral Neuromodulation Trial in Odense (Turning ON the
Recruiting
- Neurogenic Dysfunction of the Urinary Bladder
- +5 more
- Turning ON the neuromodulator
- Turning OFF the neuromodulator
-
Odense, Fyn, DenmarkOdense University Hospital
May 15, 2022
Opioid Use Disorder Trial in Overland Park (Morphine Sulfate)
Recruiting
- Opioid Use Disorder
- Morphine Sulfate
-
Overland Park, KansasAltaSciences
Feb 17, 2022
Schizophrenia; Psychosis Trial in Nashville (Levetiracetam 500 mg)
Terminated
- Schizophrenia; Psychosis
- Levetiracetam 500 mg
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 14, 2021
Normal Physiology Trial run by the National Institute of Mental Health (NIMH) (3T and 7T device)
Recruiting
- Normal Physiology
- 3T and 7T device
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022